Does Sanofi produce mRna Covid vaccine?

Sanofi does not produce an mRNA COVID-19 vaccine. Instead, they produce a protein-based non-mRNA adjuvanted COVID-19 vaccine in collaboration with Novavax. Under the co-exclusive licensing agreement, Sanofi has a sole license to Novavax's adjuvanted COVID-19 vaccine for use in combination with Sanofi's flu vaccines. This collaboration allows Sanofi to offer patients a broader access to a non-mRNA COVID-19 vaccine with demonstrated efficacy and tolerability, potentially providing enhanced convenience and protection against COVID-19 and influenza.